203 related articles for article (PubMed ID: 23925889)
1. Identification of polyproline II regions derived from the proline-rich nuclear receptor coactivators PNRC and PNRC2: new insights for ERα coactivator interactions.
Byrne C; Miclet E; Broutin I; Gallo D; Pelekanou V; Kampa M; Castanas E; Leclercq G; Jacquot Y
Chirality; 2013 Oct; 25(10):628-42. PubMed ID: 23925889
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis of the interaction between the proline-rich SH3-binding motif of PNRC and estrogen receptor alpha.
Zhou D; Ye JJ; Li Y; Lui K; Chen S
Nucleic Acids Res; 2006; 34(20):5974-86. PubMed ID: 17068076
[TBL] [Abstract][Full Text] [Related]
3. PNRC2 is a 16 kDa coactivator that interacts with nuclear receptors through an SH3-binding motif.
Zhou D; Chen S
Nucleic Acids Res; 2001 Oct; 29(19):3939-48. PubMed ID: 11574675
[TBL] [Abstract][Full Text] [Related]
4. PNRC: a proline-rich nuclear receptor coregulatory protein that modulates transcriptional activation of multiple nuclear receptors including orphan receptors SF1 (steroidogenic factor 1) and ERRalpha1 (estrogen related receptor alpha-1).
Zhou D; Quach KM; Yang C; Lee SY; Pohajdak B; Chen S
Mol Endocrinol; 2000 Jul; 14(7):986-98. PubMed ID: 10894149
[TBL] [Abstract][Full Text] [Related]
5. Diverse recognition of non-PxxP peptide ligands by the SH3 domains from p67(phox), Grb2 and Pex13p.
Kami K; Takeya R; Sumimoto H; Kohda D
EMBO J; 2002 Aug; 21(16):4268-76. PubMed ID: 12169629
[TBL] [Abstract][Full Text] [Related]
6. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
7. Novel Src homology 3 domain-binding motifs identified from proteomic screen of a Pro-rich region.
Jia CY; Nie J; Wu C; Li C; Li SS
Mol Cell Proteomics; 2005 Aug; 4(8):1155-66. PubMed ID: 15929943
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha--identification by a modeling approach of a potential polyproline II recognizing domain within the AF-2 region of the receptor that would play a role of prime importance in its mechanism of action.
Jacquot Y; Gallo D; Leclercq G
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):1-10. PubMed ID: 17258904
[TBL] [Abstract][Full Text] [Related]
9. A novel crosstalk mechanism between nuclear receptor-mediated and growth factor/Ras-mediated pathways through PNRC-Grb2 interaction.
Zhou D; Chen B; Ye JJ; Chen S
Oncogene; 2004 Jul; 23(31):5394-404. PubMed ID: 15122321
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human estrogen receptor alpha-derived antiestrogenic peptide that adopts a polyproline II conformation.
Kapitán J; Gallo D; Goasdoué N; Nicaise M; Desmadril M; Hecht L; Leclercq G; Barron LD; Jacquot Y
J Pept Sci; 2009 Jul; 15(7):455-64. PubMed ID: 19424961
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of Src homology 3 domain association with the proline-rich domain of dynamins: specificity, occlusion, and the effects of phosphorylation.
Solomaha E; Szeto FL; Yousef MA; Palfrey HC
J Biol Chem; 2005 Jun; 280(24):23147-56. PubMed ID: 15834155
[TBL] [Abstract][Full Text] [Related]
12. 4-Fluoroproline derivative peptides: effect on PPII conformation and SH3 affinity.
Ruzza P; Siligardi G; Donella-Deana A; Calderan A; Hussain R; Rubini C; Cesaro L; Osler A; Guiotto A; Pinna LA; Borin G
J Pept Sci; 2006 Jul; 12(7):462-71. PubMed ID: 16506148
[TBL] [Abstract][Full Text] [Related]
13. The impact of either 4-R-hydroxyproline or 4-R-fluoroproline on the conformation and SH3m-cort binding of HPK1 proline-rich peptide.
Borgogno A; Ruzza P
Amino Acids; 2013 Feb; 44(2):607-14. PubMed ID: 22976002
[TBL] [Abstract][Full Text] [Related]
14. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the thermodynamics of binding of an SH3 domain to proline-rich peptides using a chimeric fusion protein.
Candel AM; van Nuland NA; Martin-Sierra FM; Martinez JC; Conejero-Lara F
J Mol Biol; 2008 Mar; 377(1):117-35. PubMed ID: 18234212
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
17. Circular dichroic investigation of the native and non-native conformational states of the growth factor receptor-binding protein 2 N-terminal src homology domain 3: effect of binding to a proline-rich peptide from guanine nucleotide exchange factor.
Bousquet JA; Garbay C; Roques BP; Mély Y
Biochemistry; 2000 Jul; 39(26):7722-35. PubMed ID: 10869177
[TBL] [Abstract][Full Text] [Related]
18. Disrupting the intramolecular interaction between proto-oncogene c-Src SH3 domain and its self-binding peptide PPII with rationally designed peptide ligands.
Zhou P; Hou S; Bai Z; Li Z; Wang H; Chen Z; Meng Y
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1122-1131. PubMed ID: 28754059
[TBL] [Abstract][Full Text] [Related]
19. A miniprotein scaffold used to assemble the polyproline II binding epitope recognized by SH3 domains.
Cobos ES; Pisabarro MT; Vega MC; Lacroix E; Serrano L; Ruiz-Sanz J; Martinez JC
J Mol Biol; 2004 Sep; 342(1):355-65. PubMed ID: 15313630
[TBL] [Abstract][Full Text] [Related]
20. Why the first self-binding peptide of human
Zhou P; Yan F; Miao Q; Chen Z; Wang H
J Biomol Struct Dyn; 2021 Jan; 39(1):310-318. PubMed ID: 31872783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
